The expression of FUT2 in lung adenocarcinoma tissues was higher than that in adjacent noncancerous tissue (P < 0.0001), but there were no difference among the clinical stages I, II and III (P > 0.05). The gene discussed is FUT2; the disease is lung adenocarcinoma.